Signature Equity Partners’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$195K Buy
6,193
+1,220
+25% +$38.4K 0.1% 181
2025
Q4
$147K Buy
+4,973
New +$138K 0.08% 215

Other funds holding RTO

Signature Equity Partners's RTO Position: Q1 2026 in Review

Signature Equity Partners increased its Rentokil (RTO) stake by 25% in Q1 2026, buying an estimated $38.4K and bringing the position to 6,193 shares worth $195K. The position accounts for 0.1% of the portfolio, ranked #181.

Signature Equity Partners first reported a position in RTO in Q4 2025 and has held it in 2 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Signature Equity Partners held 6,193 shares of Rentokil worth $195K as of Q1 2026.
  • Signature Equity Partners bought 1,220 Rentokil shares in Q1 2026, an estimated $38.4K.
  • Rentokil made up 0.1% of Signature Equity Partners's portfolio in Q1 2026, its #181 holding.
  • Signature Equity Partners first reported a position in Rentokil in Q4 2025 and has held it in 2 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Signature Equity Partners's 13F filing for Q1 2026, filed 13 May 2026.